Resolve Therapeutics
Latest round
- Series B
Last raised
- Nov 2012
Total raised
- $7.8M
Investors
- 3
About Resolve Therapeutics
Resolve Therapeutics is based in US and operates as a biotechnology company which engages in research of biologic compounds for the patients suffering from lupus.
Who invested in Resolve Therapeutics
3 investors across 2 rounds
See all investors in Resolve Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Resolve Therapeutics
Who invested in Resolve Therapeutics?
Resolve Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Resolve Therapeutics raised?
Resolve Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Resolve Therapeutics last raise money?
Resolve Therapeutics's most recent round on record is a Series B, in Nov 2012.
What does Resolve Therapeutics do?
Resolve Therapeutics is based in US and operates as a biotechnology company which engages in research of biologic compounds for the patients suffering from lupus.
Where is Resolve Therapeutics headquartered?
Resolve Therapeutics is headquartered in Kirkland, US.
Which VCs invest in companies like Resolve Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Resolve Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Resolve Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.